Clinical Trials
All Clinical Trials - Page 54 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT01628445Phase 3Terminated
Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin
Liraglutide
- NCT01667900Phase 1Completed
A Study of Dulaglutide in Chinese Participants
Dulaglutide
- NCT01524705Phase 4Completed
FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
Exenatide
- NCT01776788Phase 4Completed
Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients
Exenatide
- NCT02090244Phase 4Completed
Does PTH 1-34 (Teriparatide) Enhance Spinal Fusion in Humans?
Teriparatide
- NCT01656629N/ATerminated
Stem Cell Recruitment in Osteoporosis Therapy
Teriparatide
- NCT01673906Phase 2Completed
68-Ga-labeled Octreotide Analogues PET in Duodenal-pancreatic Neuroendocrine Tumours
Octreotide
- NCT01841515Phase 1Completed
Effect of Desmopressin on Platelet Function in CKD Patients on Antiplatelet Drug
Desmopressin
- NCT01642914Phase 3Completed
Safety and Efficacy of Linaclotide in Patients With Chronic Constipation and Prominent Abdominal Bloating
Linaclotide
- NCT01642186Phase 2Completed
Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)
Gonadorelin
- NCT02721888Phase 4Terminated
Effect of Liraglutide on Fatty Liver Content and Lipoprotein Metabolism
Liraglutide
- NCT01669291N/ACompleted
Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation
Gonadorelin
- NCT01669460Phase 2Completed
Study of Red Bull™ Sugar-Free Drink for Reduction of Fatigue in Prostate Cancer Patients Receiving LHRH Agonist Therapy
Gonadorelin
- NCT01732094Phase 2Completed
Corifollitropin Alfa Followed by hpHMG in a Long GnRH Agonist Protocol for the Treatment of Poor Ovarian Responders
Gonadorelin
- NCT01658501Phase 2Completed
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Liraglutide
- NCT01795248Phase 4Completed
The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Pregnancy-induced Diabetes
Liraglutide
- NCT01648582Phase 3Completed
A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus
Dulaglutide
- NCT01644500Phase 3Completed
A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes Mellitus
Dulaglutide
- NCT01621178Phase 3Completed
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Dulaglutide
- NCT01664624Phase 1Completed
Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes
Exenatide
- NCT01469338Phase 2Terminated
Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel
Octreotide
- NCT01620489Phase 3Completed
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Liraglutide
- NCT01667406Phase 2Completed
The Use of the Hormone Kisspeptin in 'in Vitro Fertilisation' (IVF) Treatment
Kisspeptin
- NCT01591902Phase 4Terminated
Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®
Tesamorelin
- NCT01597531Phase 4Terminated
Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding
Liraglutide
- NCT01715428N/ACompleted
Liraglutide and Cardio-Metabolic Risk Markers
Liraglutide
- NCT01612468Phase 4Completed
Liraglutide in Type 1 Diabetes
Liraglutide
- NCT01592279Phase 4Unknown
GLP-1 Analogue Treatment in Uncontrolled Type 1 Diabetic Patients
Liraglutide
- NCT01624259Phase 3Completed
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
Liraglutide
- NCT01484873Phase 2Completed
Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor
Exenatide
- NCT01618513Phase 4Completed
Treatment of Acromegaly With Somatostatin Analogs: GH vs. IGF-I as Primary Biochemical Target
Octreotide
- NCT01840449N/ACompleted
Somatuline Predictive Factors in Acromegaly and NET
Lanreotide
- NCT01616927Phase 3Unknown
Study of Lanreotide to Treat Polycystic Kidney Disease
Lanreotide
- NCT01560403Phase 3Completed
A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021
Teduglutide
- NCT01788462N/AWithdrawn
Egrifta Replacement and Sleep Disordered Breathing
Tesamorelin
- NCT01605136Phase 3Completed
Phase III Confirmatory Study in Erythropoietic Protoporphyria
Afamelanotide
- NCT01546987Phase 3Completed
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
Gonadorelin
- NCT01593137Phase 4Withdrawn
A Long-term Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 Diabetes
Liraglutide
- NCT01595789Phase 4Completed
The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes
Liraglutide
- NCT01550653Phase 1Completed
Liraglutide Effects on Memory in Healthy Subjects
Liraglutide
- NCT02516657Phase 3Completed
Liraglutide in Adolescents With Type 1 Diabetes
Liraglutide
- NCT01596504Phase 2Completed
Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without Metformin
Liraglutide
- NCT01572649Phase 1Completed
Evaluation of the Blood Levels of the Drug (Lixisenatide), the Plasma Glucose Levels and Safety in Paediatric and Adult Patients With Type 2 Diabetes
Lixisenatide
- NCT01734824Phase 4Suspended
Treatment of Atraumatic Bone Marrow Edema With Denosumab and Teriparatide vs Placebo
Teriparatide
- NCT02068560N/ACompleted
The Effect of Gender on Antidiuresis - Evaluated by Graded Low Dose Desmopressin Infusion
Desmopressin
- NCT01572753Phase 1Completed
Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in Healthy Male Subjects
Semaglutide
- NCT01572740Phase 3Completed
Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes
Liraglutide
- NCT01572909Phase 2Completed
Evaluation of Myocardial Effects of MTP-131 for Reducing Reperfusion Injury in Patients With Acute Coronary Events
Elamipretide
- NCT01595334N/AUnknown
Study on Influence of Leutinizing Hormone (LH) on Oocyte Maturity
Gonadorelin
- NCT01584232Phase 3Completed
A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus
Dulaglutide